NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019
Deborah K. Armstrong(Johns Hopkins University), Anita M. Engh(Ithaka Harbors), Ronald D. Alvarez(Vanderbilt University Medical Center), Karen McLean(University of Michigan), David M. Gershenson(The University of Texas MD Anderson Cancer Center), Elena Ratner(Yale University), David M. O’Malley(The Ohio State University), Jennifer L. Burns(National Comprehensive Cancer Network), Jonathan S. Berek(Stanford Health Care), Jamie N. Bakkum‐Gamez(Mayo Clinic in Arizona), Sanja Percac‐Lima(Massachusetts General Hospital), Andrew Berchuck(General Marble (Greece)), Steven W. Remmenga(Roche (Switzerland)), Adam C. ElNaggar(St. Jude Children's Research Hospital), Marie DeRosa(Children's Advocacy Center), Angela Jain(Fox Chase Cancer Center), Mihaela Cristea(City Of Hope National Medical Center), Theresa L. Werner(University of Utah), Kian Behbakht(University of Colorado Cancer Center), Emese Zsíros, Heidi J. Gray(Seattle Cancer Care Alliance), Joyce F. Liu(Duke University), Lisa Barroilhet(University of Wisconsin–Madison), Daniela Matei(Northwestern University), Carolyn Johnston(University of Tasmania), Haider Mahdi(Magee-Womens Hospital), Richard T. Penson(Massachusetts General Hospital), Paul Sabbatini(Memorial Sloan Kettering Cancer Center), Michael McHale(University of California, San Diego), Lee-may Chen(Apple (Israel)), Ardeshir Hakam(Roche (Switzerland)), Charles A. Leath(University of Alabama at Birmingham)
Cited by 332
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k